CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Vivaer Stylusdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02914236
NCT02914236N/ACompleted

A Prospective, Multi-Center Non-Randomized Study to Evaluate Treatment of Nasal Airway Obstruction Using the Aerin Medical Device

Aerin Medical·interventional·Posted Sep 26, 2016·Updated May 21, 2019

In Brief

A clinical study evaluating Vivaer Stylus for Nasal Obstruction. Completed, enrolled 50 participants across 9 sites.

Detailed Summary

Evaluation of the Aerin Medical Device used for the treatment of nasal obstruction.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedSep 26, 2016
Enrollment StartSep 27, 2016
Primary CompletionJul 21, 2017
Study CompletionAug 18, 2017
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 9.8 years ago

Interventions

Vivaer Stylusdevice

Delivery of low-power, temperature-controlled, radiofrequency energy to the tissues of the internal nasal valve area